Plain Language Summaries is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • How to
  • FAQs
  • Publications
  • Advisory Panel
    • Plain Language Advisors
    • Scientific Content Advisors
  • Supporters
  • Blog
  • About us
  • Contact Us

Novel Technologies and Treatments

22nd Jan 2026

Meeting care goals through ongoing botulinum toxin therapy for leg spasticity in adults: plain language summary

28th Aug 2025

Examining empagliflozin’s safety profile across four clinical trials: a plain language summary

27th May 2025

Plain language summary: clinical study findings on rimegepant melt-in-mouth tablets for treating migraine attacks

20th Sep 2022

Plain language summary of the VOLTAIRE-RA study in patients with moderate-to-severe rheumatoid arthritis

Copyright © 2026 · Plain Language Summaries · Terms and conditions · Privacy policy · Cookie policy